Azfar, 2008, Psoriasis and metabolic disease: epidemiology and pathophysiology, Curr Opin Rheumatol, 20, 416, 10.1097/BOR.0b013e3283031c99
Gelfand, 2007, The risk of mortality in patients with psoriasis: results from a population-based study, Arch Dermatol, 143, 1493, 10.1001/archderm.143.12.1493
Gelfand, 2006, Risk of myocardial infarction in patients with psoriasis, JAMA, 296, 1735, 10.1001/jama.296.14.1735
Neimann, 2006, Prevalence of cardiovascular risk factors in patients with psoriasis, J Am Acad Dermatol, 55, 829, 10.1016/j.jaad.2006.08.040
Kurd, 2007, An update on the epidemiology and systemic treatment of psoriasis, Expert Rev Clin Immunol, 3, 171, 10.1586/1744666X.3.2.171
Gelfand, 2008, Incidence of stroke in patients with psoriasis: a population–based study, J Invest Dermatol, 128, S81
Pariser, 2007, National Psoriasis Foundation clinical consensus on disease severity, Arch Dermatol, 143, 239, 10.1001/archderm.143.2.239
Gelfand, 2007, Long-term treatment for severe psoriasis: we're halfway there, with a long way to go, Arch Dermatol, 143, 1191, 10.1001/archderm.143.9.1191
Koo, 1996, Population-based epidemiologic study of psoriasis with emphasis on quality of life assessment, Dermatol Clin, 14, 485, 10.1016/S0733-8635(05)70376-4
Johnson, 1978, Skin conditions and related need for medical care among persons 1-74 years. United States, 1971-1974, Vital Health Stat, 11, 72
Nevitt, 1996, Psoriasis in the community: prevalence, severity and patients' beliefs and attitudes towards the disease, Br J Dermatol, 135, 533, 10.1111/j.1365-2133.1996.tb03826.x
Yip, 1984, The prevalence of psoriasis in the Mongoloid race, J Am Acad Dermatol, 10, 965, 10.1016/S0190-9622(84)80314-X
Gelfand, 2005, Prevalence and treatment of psoriasis in the United Kingdom: a population-based study, Arch Dermatol, 141, 1537, 10.1001/archderm.141.12.1537
Psoriasis, 1964, A statistical, clinical and laboratory investigation of 255 psoriatics and matched healthy controls, Acta Derm Venereol, 44, 191
Kavli, 1985, Low prevalence of psoriasis in Norwegian lapps, Acta Derm Venereol, 65, 262
Ferrandiz, 2001, Prevalence of psoriasis in Spain (Epiderma Project: phase I), J Eur Acad Dermatol Venereol, 15, 20, 10.1046/j.1468-3083.2001.00191.x
Lomholt, 1954, Psoriasis on the Faroe Islands; a preliminary report, Acta Derm Venereol, 34, 92
Barisic-Drusko, 1989, Prevalence of psoriasis in Croatia, Acta Derm Venereol Suppl (Stockh), 146, 178
Brandrup, 1981, The prevalence of psoriasis in Denmark, Acta Derm Venereol, 61, 344, 10.2340/0001555561344346
Naldi, 2004, Epidemiology of psoriasis, Curr Drug Targets Inflamm Allergy, 3, 121, 10.2174/1568010043343958
Falk, 1993, Prevalence of psoriasis in a Norwegian Lapp population, Acta Derm Venereol Suppl (Stockh), 182, 6, 10.2340/0001555518269
Rea, 1976, Skin disease in Lambeth. A community study of prevalence and use of medical care, Br J Prev Soc Med, 30, 107
Gelfand, 2005, The prevalence of psoriasis in African Americans: results from a population-based study, J Am Acad Dermatol, 52, 23, 10.1016/j.jaad.2004.07.045
Stern, 2004, Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction, J Investig Dermatol Symp Proc, 9, 136, 10.1046/j.1087-0024.2003.09102.x
Neimann, 2006, The epidemiology of psoriasis, Expert Rev Dermatol, 1, 63, 10.1586/17469872.1.1.63
Kavli, 1985, Psoriasis: familial predisposition and environmental factors, Br Med J (Clin Res Ed), 291, 999, 10.1136/bmj.291.6501.999
Gelfand, 2004, Determinants of quality of life in patients with psoriasis: a study from the US population, J Am Acad Dermatol, 51, 704, 10.1016/j.jaad.2004.04.014
National Psoriasis Foundation. About psoriasis: statistics. Available at: http://www.psoriasis.org/about/stats/. Accessed November 6, 2008.
Landis, 1977, The measurement of observer agreement for categorical data, Biometrics, 33, 159, 10.2307/2529310
Gelfand, 2005, Epidemiology of psoriatic arthritis in the population of the United States, J Am Acad Dermatol, 53, 573, 10.1016/j.jaad.2005.03.046
Feldman, 1996, The self-administered psoriasis area and severity index is valid and reliable, J Invest Dermatol, 106, 183, 10.1111/1523-1747.ep12329912
Martin, 2000, Validation of self-reported chronic conditions and health services in a managed care population, Am J Prev Med, 18, 215, 10.1016/S0749-3797(99)00158-0